 | • レポートコード：D005-00969 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、外科用止血剤・内部組織シーラント・接着バリアの世界市場を広く調査・分析し、今後の市場展望をまとめております。外科用止血剤・内部組織シーラント・接着バリアの種類別市場規模（止血剤、内部組織シーラント、接着バリア）、用途別市場規模（病院、クリニック＆外傷センター、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Baxter、Tissuemed、Sanofi、Ethicon、Cryolife、B. Braun Melsungen、Pfizer、Integra Lifesciences、C. R. Bard、Cohera Medical ・地域別グローバル市場分析 2015年-2020年 ・外科用止血剤・内部組織シーラント・接着バリアの北米市場（アメリカ、カナダ、メキシコ） ・外科用止血剤・内部組織シーラント・接着バリアのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・外科用止血剤・内部組織シーラント・接着バリアのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・外科用止血剤・内部組織シーラント・接着バリアの南米市場（ブラジル、アルゼンチン） ・外科用止血剤・内部組織シーラント・接着バリアの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：止血剤、内部組織シーラント、接着バリア ・用途別分析：病院、クリニック＆外傷センター、外来手術センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 5460 million by 2025, from USD 4194.6 million in 2019.
The Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market has been segmented into:
Hemostats
Internal Tissue Sealants
Adhesion Barriers
By Application, Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers has been segmented into:
Hospitals
Clinics & Trauma Centers
Ambulatory Surgical Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market presented in the report. This section sheds light on the sales growth of different regional and country-level Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market.
The report offers in-depth assessment of the growth and other aspects of the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share Analysis
Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers sales, revenue and market share for each player covered in this report.
The major players covered in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers are:
Baxter
Tissuemed
Sanofi
Ethicon
Cryolife
B. Braun Melsungen
Pfizer
Integra Lifesciences
C. R. Bard
Cohera Medical
Table of Contents
1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Overview
1.1 Product Overview and Scope of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
1.2 Classification of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Type
1.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type in 2019
1.2.3 Hemostats
1.2.4 Internal Tissue Sealants
1.2.5 Adhesion Barriers
1.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Application
1.3.1 Overview: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics & Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Regions
1.4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Baxter SWOT Analysis
2.1.4 Baxter Product and Services
2.1.5 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tissuemed
2.2.1 Tissuemed Details
2.2.2 Tissuemed Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Tissuemed SWOT Analysis
2.2.4 Tissuemed Product and Services
2.2.5 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ethicon
2.4.1 Ethicon Details
2.4.2 Ethicon Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ethicon SWOT Analysis
2.4.4 Ethicon Product and Services
2.4.5 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cryolife
2.5.1 Cryolife Details
2.5.2 Cryolife Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cryolife SWOT Analysis
2.5.4 Cryolife Product and Services
2.5.5 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.6 B. Braun Melsungen
2.6.1 B. Braun Melsungen Details
2.6.2 B. Braun Melsungen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 B. Braun Melsungen SWOT Analysis
2.6.4 B. Braun Melsungen Product and Services
2.6.5 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.8 Integra Lifesciences
2.8.1 Integra Lifesciences Details
2.8.2 Integra Lifesciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Integra Lifesciences SWOT Analysis
2.8.4 Integra Lifesciences Product and Services
2.8.5 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.9 C. R. Bard
2.9.1 C. R. Bard Details
2.9.2 C. R. Bard Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 C. R. Bard SWOT Analysis
2.9.4 C. R. Bard Product and Services
2.9.5 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cohera Medical
2.10.1 Cohera Medical Details
2.10.2 Cohera Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cohera Medical SWOT Analysis
2.10.4 Cohera Medical Product and Services
2.10.5 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players Market Share
3.2.2 Top 10 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Market Share by Regions
4.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
4.3 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
4.5 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
5 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries
5.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries (2015-2020)
5.2 USA Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
5.3 Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
5.4 Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
6 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries
6.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries (2015-2020)
6.2 Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
6.3 UK Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
6.4 France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
6.5 Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
6.6 Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries
7.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries (2015-2020)
7.2 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
7.3 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
7.4 Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
7.5 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
8 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries
8.1 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries (2015-2020)
8.2 Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
8.3 Argentina Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Countries
9.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
9.3 UAE Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
9.4 Egypt Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
9.5 South Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Market Share by Type (2015-2020)
10.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Forecast by Type (2019-2024)
10.3 Hemostats Revenue Growth Rate (2015-2025)
10.4 Internal Tissue Sealants Revenue Growth Rate (2015-2025)
10.5 Adhesion Barriers Revenue Growth Rate (2015-2025)
11 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Segment by Application
11.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application (2015-2020)
11.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics & Trauma Centers Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Forecast (2021-2025)
12.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Forecast (2021-2025)
12.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Forecast by Regions (2021-2025)
12.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
12.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
12.6 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Baxter Corporate Information, Location and Competitors
Table 6. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 7. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 8. Baxter SWOT Analysis
Table 9. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 10. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Tissuemed Corporate Information, Location and Competitors
Table 12. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 13. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2018-2019)
Table 14. Tissuemed SWOT Analysis
Table 15. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 16. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 19. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 22. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Ethicon Corporate Information, Location and Competitors
Table 24. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 25. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 26. Ethicon SWOT Analysis
Table 27. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 28. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cryolife Corporate Information, Location and Competitors
Table 30. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 31. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 32. Cryolife SWOT Analysis
Table 33. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 34. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. B. Braun Melsungen Corporate Information, Location and Competitors
Table 36. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 37. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 38. B. Braun Melsungen SWOT Analysis
Table 39. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 40. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Corporate Information, Location and Competitors
Table 42. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 43. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 46. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Integra Lifesciences Corporate Information, Location and Competitors
Table 48. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 49. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 50. Integra Lifesciences SWOT Analysis
Table 51. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 52. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. C. R. Bard Corporate Information, Location and Competitors
Table 54. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 55. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 56. C. R. Bard SWOT Analysis
Table 57. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 58. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Cohera Medical Corporate Information, Location and Competitors
Table 60. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Business
Table 61. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Total Revenue (USD Million) (2017-2018)
Table 62. Cohera Medical SWOT Analysis
Table 63. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product and Solutions
Table 64. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Players (2015-2020)
Table 66. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Players (2015-2020)
Table 67. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Regions (2015-2020)
Table 69. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries (2015-2020)
Table 70. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Table 71. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Countries (2015-2020)
Table 74. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Table 77. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Type (2015-2020)
Table 78. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Type (2015-2020)
Table 79. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Forecast by Type (2021-2025)
Table 80. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Application (2015-2020)
Table 81. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Application (2015-2020)
Table 82. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Forecast by Application (2021-2025)
Table 83. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Picture
Figure 2. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type in 2019
Figure 3. Hemostats Picture
Figure 4. Internal Tissue Sealants Picture
Figure 5. Adhesion Barriers Picture
Figure 6. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics & Trauma Centers Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share in 2019
Figure 19. Global Top 10 Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Regions (2015-2020)
Figure 23. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Regions in 2018
Figure 24. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 25. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 27. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 29. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Figure 30. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries in 2019
Figure 31. USA Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 32. Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 34. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries in 2019
Figure 36. Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 37. UK Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 38. France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 39. Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 40. Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries in 2019
Figure 43. China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 44. Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 45. Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 46. India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 48. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Figure 49. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries in 2019
Figure 50. Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 55. UAE Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue and Growth Rate (2015-2020)
Figure 58. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Type (2015-2020)
Figure 59. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Type in 2019
Figure 60. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share Forecast by Type (2021-2025)
Figure 61. Global Hemostats Revenue Growth Rate (2015-2020)
Figure 62. Global Internal Tissue Sealants Revenue Growth Rate (2015-2020)
Figure 63. Global Adhesion Barriers Revenue Growth Rate (2015-2020)
Figure 64. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Application (2015-2020)
Figure 65. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Application in 2019
Figure 66. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics & Trauma Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
Figure 74. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
Figure 76. South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
外科用癒着防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Surgical Anti-Adhesion market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Surgical Anti-Adhesion…- 組織接着剤＆生体接着性シーラントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tissue Glue and Bio-adhesive Sealants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tissue …
- 外科用接着剤＆シーラントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Surgical Adhesives and Sealants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Surgical Adhe…
- 軟部組織同種移植片の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Soft Tissue Allografts market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 3498.8 million by 2025, from USD 2881.1 million in 2019. The Soft Tissue A…
- 歯科用接着剤＆シーラントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dental Adhesives & Sealants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dental Adhesives …